in the case of blu tangu have benefited from the back we supported research and now have an inactivated vaccine and are able to out comprehensive vaccination which was previously
In the case of bluetongue, we have, of course, benefited from the fact that we supported research and now have an inactivated vaccine and are able to carry out comprehensive vaccination, which was previously very dangerous and very difficult.
In the case of bluetongue, have, benefited from the that we supported research and now have an inactivated vaccine and are able to out comprehensive vaccination, which was previously very dangerous difficult.